In three established T-ALL cell lines, both phenformin and rapamycin inhibited mTORC1; reduced expression of HIF1A, ALDOA, and LDHA; and increased expression of the cell cycle inhibitor CDKN1B. This evidence concerns the gene ALDOA and acute lymphoblastic leukemia.